"Nanobody-Based CAR-T Cell Therapies: VHH-CAR-Ts Targeting CD33 for the Treatment of AML"

"Nanobody-Based CAR-T Cell Therapies: VHH-CAR-Ts Targeting CD33 for the Treatment of AML", keynote lecture of Therapeutic Innovations Program by Franco Bernasconi.

• 9.15 h
• Cima´s Main Hall